Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.
NCT01561313
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL:
Adalimumab
Sponsor
AbbVie (prior sponsor, Abbott)